Pendrin does not increase sulfate uptake in mammalian COS-7 cells

J Endocrinol Invest. 2000 Mar;23(3):170-2. doi: 10.1007/BF03343701.

Abstract

Pendred's syndrome is characterized by goiter, sensorineural deafness and impaired iodide organification. It is one of the most frequent causes of congenital deafness accounting for about 10% of hereditary hearing loss. It is caused by mutations in the pendrin (PDS) gene, which was postulated to be a sulfate transporter, because of its homology with other genes. We tested sulfate transport in mammalian COS-7 cells that were transiently transfected with PDS cDNA. 35SO4 uptake increased in a time-dependent manner, but this phenomenon was similar in cells transfected with PDS and in mock-transfected cells (450 and 360 cpm/beta-gal units at 10 min, respectively; 38,250 and 31,000 cpm/beta-gal units, at 12 h, respectively). There was no significant increase in 35SO4 uptake using increasing amounts of PDS-containing plasmid (up to 12 microg per dish). These data indicate that pendrin is not a sulfate transporter. Additional functional studies on this protein are warranted to clarify its role in thyroid pathophysiology and inner ear development.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biological Transport / physiology
  • COS Cells
  • Carrier Proteins / biosynthesis
  • Carrier Proteins / genetics
  • Carrier Proteins / physiology*
  • DNA, Complementary / biosynthesis
  • Membrane Transport Proteins*
  • Plasmids / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sulfate Transporters
  • Sulfates / metabolism*
  • Sulfur Radioisotopes
  • Transfection / genetics

Substances

  • Carrier Proteins
  • DNA, Complementary
  • Membrane Transport Proteins
  • SLC26A4 protein, human
  • Sulfate Transporters
  • Sulfates
  • Sulfur Radioisotopes